495 related articles for article (PubMed ID: 18293659)
1. A drug-resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient.
Lopez-Roa RI; Fafutis-Morris M; Masanori M
Rev Latinoam Microbiol; 2006; 48(3-4):256-9. PubMed ID: 18293659
[TBL] [Abstract][Full Text] [Related]
2. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
3. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
Matsuoka M; Suzuki Y; Garcia IE; Fafutis-Morris M; Vargas-González A; Carreño-Martinez C; Fukushima Y; Nakajima C
Jpn J Infect Dis; 2010 Nov; 63(6):412-6. PubMed ID: 21099091
[TBL] [Abstract][Full Text] [Related]
4. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
You EY; Kang TJ; Kim SK; Lee SB; Chae GT
J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
[TBL] [Abstract][Full Text] [Related]
5. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
[TBL] [Abstract][Full Text] [Related]
6. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
[TBL] [Abstract][Full Text] [Related]
7. A mutation at codon 516 in the rpoB gene of Mycobacterium leprae confers resistance to rifampin.
Zhang L; Namisato M; Matsuoka M
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):468-72. PubMed ID: 15755201
[TBL] [Abstract][Full Text] [Related]
8. Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae.
Gillis TP; Williams DL
Indian J Lepr; 1999; 71(1):11-8. PubMed ID: 10439322
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance.
Nakata N; Kai M; Makino M
Antimicrob Agents Chemother; 2011 Feb; 55(2):762-6. PubMed ID: 21115799
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.
Lee SB; Kim SK; Kang TJ; Chae GT; Chun JH; Shin HK; Kim JP; Ko YH; Kim NH
Ann Trop Med Parasitol; 2001 Jun; 95(4):429-32. PubMed ID: 11454253
[No Abstract] [Full Text] [Related]
11. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
Beltrán-Alzate C; López Díaz F; Romero-Montoya M; Sakamuri R; Li W; Kimura M; Brennan P; Cardona-Castro N
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
[TBL] [Abstract][Full Text] [Related]
12. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
Guerrero MI; Colorado CL; Torres JF; León CI
Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
[TBL] [Abstract][Full Text] [Related]
13. Lepromatous leprosy of histoid type.
Annigeri SR; Metgud SC; Patil JR
Indian J Med Microbiol; 2007 Jan; 25(1):70-1. PubMed ID: 17377360
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
Liu D; Zhang Q; Sun Y; Wang C; Zhang Y; Fu X; Chen M; Zhou G; Yu X; Wang J; Liu H; Zhang F
Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
[TBL] [Abstract][Full Text] [Related]
15. Two microbiological relapses in a patient with lepromatous leprosy.
Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
[TBL] [Abstract][Full Text] [Related]
16. Dapsone resistance in Mycobacterium leprae.
Gillis TP; Williams DL
Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
[TBL] [Abstract][Full Text] [Related]
17. Active surveillance of leprosy contacts in country with low prevalence rate.
Kai M; Maeda Y; Maeda S; Fukutomi Y; Kobayashi K; Kashiwabara Y; Makino M; Abbasi MA; Khan MZ; Shah PA
Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):50-3. PubMed ID: 15217314
[TBL] [Abstract][Full Text] [Related]
18. Viability and drug susceptibility testing of M. leprae using mouse footpad in 37 relapse cases of leprosy.
Shetty VP; Wakade AV; Ghate S; Pai VV; Ganapati R; Antia NH
Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):210-7. PubMed ID: 14608816
[TBL] [Abstract][Full Text] [Related]
19. [Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene].
Kai M
Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):221-6. PubMed ID: 15508724
[TBL] [Abstract][Full Text] [Related]
20. Reverse line probe assay for the rapid detection of rifampicin resistance in Mycobacterium leprae.
Sapkota BR; Ranjit C; Macdonald M
Nepal Med Coll J; 2006 Jun; 8(2):122-7. PubMed ID: 17017404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
